Loading...

Home
ETF
GOSS

GOSS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

GOSS News

Gossamer Bio (GOSS) Options Trading Volume Hits 36,131 Contracts, 73.1% of Average Daily Volume

Jan 21 2026NASDAQ.COM

Gossamer Bio Grants 212,500 Stock Options to Employees Under 2023 Inducement Plan

Jan 08 2026Businesswire

Gossamer Bio Options Volume Hits 41,590 Contracts, Significantly Above Average

Jan 07 2026NASDAQ.COM

Oppenheimer Optimistic About Favorable PROSERA Trial Results for Gossamer Bio (GOSS) Expected in February 2026

Dec 16 2025Yahoo Finance

Gossamer Bio Grants 200,000 Stock Options to Attract New Employee

Dec 09 2025Newsfilter

Gossamer Bio Reveals Inducement Grant in Accordance with Nasdaq Listing Rule 5635(c)(4)

Nov 07 2025Newsfilter

Gossamer Bio to Attend Upcoming Investor Conferences

Nov 07 2025Newsfilter

Software Company Explores IPO Opportunities Amid Shutdown

Top Analysts Recommend 3 Stocks to Purchase Now, 9/26/2025

Sep 26 2025TipRanks

Gossamer Bio Signs Option Agreement to Acquire Respira Therapeutics and Its Primary Candidate, RT234, an Inhaled On-Demand Vardenafil for Treating Pulmonary Hypertension

Sep 25 2025Newsfilter

Gossamer Bio obtains option to purchase Respira Therapeutics

Sep 25 2025SeekingAlpha

Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital

Sep 25 2025PRnewswire

Gossamer Bio to Present at the 2025 European Respiratory Society Congress

Sep 22 2025Newsfilter

Gossamer Bio Reveals Inducement Grant in Accordance with Nasdaq Listing Rule 5635(c)(4)

Sep 10 2025Newsfilter

Saia Analyst Becomes Optimistic; Check Out the Top 4 Upgrades for Wednesday

Sep 10 2025Benzinga

Most Active Stocks After Hours on September 2, 2025: T, GOOGL, GOOG, GOSS, AAPL, NVDA, HPE, F, BAC, OPEN, JNJ, WMB

Sep 02 2025NASDAQ.COM